Morning Market Gainers

shares jumped 40.51% to $38.33 after

announced its plans to acquire RTI International for $1.5 billion.

shares gained 22.45% to $9.00 after the company reported that it has received the FDA Fast Track Designation for HS-410 treatment.

shares surged 20.98% to $3.98 after the company announced its plans to acquire IV/IM Meloxicam, Gainesville, GA GMP manufacturing facility and business unit from Alkermes for $50 million.

shares gained 19.99% to $32.90 after

offered to acquire Pinnacle real estate assets for GLPI shares in a transaction valued at $4.1 billion, including debt.

shares jumped 14% to $1.71. RBC Capital upgraded AVEO Pharmaceuticals from Underperform to Sector Perform and raised the price target from $2.00 to $3.00.

shares rose 12.34% to $38.23 following a report that the company is seeking a buyer.

shares climbed 7.21% to $13.50. FBR Capital upgraded UTi Worldwide from Market Perform to Outperform and raised the price target from $11.00 to $19.00.

shares gained 5.19% to $3.24 after the company reported the receipt of an order for 9 Eagle-i systems from a global semiconductor company.

rose 5.09% to $2.79 following the announcement of positive top-line results from Phase 3 Persist-1 trial of pacritinib for patients with myelofibrosis.

shares climbed 2.32% to $2.17. BioLineRx priced its underwritten public offering of 12.5 million ADS at a price of $2.00 per ADS. The company will be presenting at the Annual Roth Conference in California on March 10, 2015.